TITLE

Inflammatory bowel disease free papers

PUB. DATE
April 2005
SOURCE
Gut;Apr2005 Supplement 2, Vol. 54, pA1
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents information on abstracts related to inflammatory bowel disease. According to a abstract amplification of toll-like receptor sensitivity by muramyl dipeptide is impaired in Crohn's disease associated NOD2 mutations. Both NOD2/CARD1 5 alleles are mutated in about 15% of Crohn's disease patients, but Functional effects remain unclear. Most studies have been performed in transfected cell lines, which may not reflect function in primary human cells, particularly interactions with toll-like receptor pathogen recognition pathways.
ACCESSION #
16567945

 

Related Articles

  • Lysophosphatidylcholine alters enterocyte monolayer permeability via a protein kinase C/Ca2+ mechanism. Sawai, Toshio; Lampman, Robert; Hua, Yang; Segura, Bradley; Drongowski, Robert A.; Coran, Arnold G.; Harmon, Caroll M. // Pediatric Surgery International;Oct2002, Vol. 18 Issue 7, p591 

    The activity of phospholipase A2 (PLA2) is elevated in the intestinal epithelia of patients with inflammatory bowel disease. We recently reported that PLA2 mediates the hydrolysis of phosphatidylcholine (PC) to lysophosphatidylcholine (L-PC) when both are applied to the apical surface of...

  • Inflammatory Bowel Disorders.  // Current Medical Literature: Gastroenterology;2011, Vol. 30 Issue 1, p21 

    The article discusses various research that explored the different aspects of inflammatory bowel disorders. One of the studies dealt with the changes in surgical resection rates and medical treatments for Crohn's disease. Another research focused on the association of pre-operative management...

  • Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis. Thomas, Saskia; Baumgart, Daniel // Inflammopharmacology;Feb2012, Vol. 20 Issue 1, p1 

    Crohn's disease and ulcerative colitis are two chronic inflammatory bowel diseases. Current biologic therapies are limited to blocking tumor necrosis factor alpha. However, some patients are primary non-responders, experience a loss of response, intolerance or side effects defining the urgent...

  • Information management and informatics: need for a modern pathology service. Jones, Rick; O'Connor, John // Annals of Clinical Biochemistry;May2004, Vol. 41 Issue 3, p183 

    Requirements for information technology in pathology now extend well beyond the provision of purely analytical data. With the aim of achieving seamless integration of laboratory data into the total clinical pathway, 'informatics' - the art and science of turning data into useful information - is...

  • New therapeutic approach in inflammatory bowel disease. PAPA, A.; MOCCI, G.; SCALDAFERRI, F.; BONIZZI, M.; FELICE, C.; ANDRISANI, G.; GASBARRINI, A. // European Review for Medical & Pharmacological Sciences;Jan2009 Supplement, Vol. 13 Issue S-1, p33 

    In the last decade, biologic agents, in particular infliximab and adalimumab, have deeply changed the therapeutic armamentarium of inflammatory bowel disease (IBD). However, these drugs have a number of contraindications and side-effects that physicians should know so to avoid and eventually...

  • Utilization of Health Care Resources by Individuals with Inflammatory Bowel Disease in the United States: A Profile of Time Since Diagnosis. Longobardi, Teresa; Jacobs, Phillip; Bernstein, Charles N. // American Journal of Gastroenterology;Apr2004, Vol. 99 Issue 4, p650 

    BACKGROUND: There are no cost studies of inflammatory bowel disease (IBD) that describe its impact on resource utilization or treatment costs over long periods of time. Our aim was to determine if there are observable trends in health-care resource utilization by adults with IBD depending on...

  • Acute Idiopathic Pancreatitis Complicating Active Crohn's Disease: Favorable Response to Infliximab Treatment. Triantafillidis, John K.; Cheracakis, Petros; Hereti, Irini A.; Argyros, Nikolaos; Karra, Evangelia // American Journal of Gastroenterology;Nov2000, Vol. 95 Issue 11, p3334 

    Reports on the case of a male patient with Crohn's disease involving concurrently the small and large bowel, which developed idiopathic acute pancreatitis during a severe flare-up of his underlying inflammatory bowel disease. Medical history of the patient; Response of the patient to infliximab...

  • REGIONAL ENTERITIS. Berger, Samuel S. // American Journal of Gastroenterology;Jul1956, Vol. 26 Issue 1, p81 

    Presents a case of a patient with regional enteritis. Persistence of abdominal pains suffered by the patient; Examination of the abdomen of the patient; Pathology of the regional enteritis.

  • Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Viget, N.; Vernier-Massouille, G.; Salmon-Ceron, D.; Yazdanpanah, Y.; Colombel, J.-F. // Gut;Apr2008, Vol. 57 Issue 4, p549 

    Because of the increasing use of immunosuppressive and biological drugs, the occurrence of opportunistic infections has become a key safety issue for patients with inflammatory bowel disease (IBD). Consequently, improvement of healthcare workers' knowledge of this domain is urgent. In this...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics